A functional variant of IC53 correlates with the late onset of colorectal cancer

Molecular Medicine

Volumn 17, Issue 7-8, 2011, Pages 607-618

  Chen, Jingzhou ^a   Shi, Yi ^b   Li, Ziyu ^c   Yu, Hui ^a   Han, Yu ^a   Wang, Xiaojian ^a   Sun, Kai ^a   Yang, Tao ^a   Lou, Kejia ^a   Song, Yan ^a   Zhang, Yinhui ^a   Zhen, Yisong ^a   Zhang, Guiguo ^c   Hu, Ying ^c   Ji, Jiafu ^c   Hui, Rutai ^a  

^a FUWAI HOSPITAL   (China)

^b SICHUAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

^c Department of Biochemistry and Molecular BiologyCancer Hospital of Peking University   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTEGRIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; CANCER GROWTH; CANCER INCIDENCE; CANCER STAGING; CARCINOGENESIS; CELL ADHESION; CELL PROLIFERATION; COLORECTAL CANCER; CONTROLLED STUDY; ENZYME ACTIVATION; EXPRESSED SEQUENCE TAG; FEMALE; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENE OVEREXPRESSION; GENETIC VARIABILITY; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IC53 GENE; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PURIFICATION; RNA TRANSLATION; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR GROWTH; UPREGULATION;

AGE OF ONSET; AGED; ANIMALS; COLORECTAL NEOPLASMS; FEMALE; GENOTYPE; HCT116 CELLS; HT29 CELLS; HUMANS; INTEGRINS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; MIDDLE AGED; NEOPLASM TRANSPLANTATION; NERVE TISSUE PROTEINS; NIH 3T3 CELLS; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTO-ONCOGENE PROTEINS C-AKT; RNA INTERFERENCE; TRANSPLANTATION, HETEROLOGOUS;

EID: 79960713660     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2010.00192     Document Type: Article

References (39)

1. Potter JD. (1999) Colorectal cancer: molecules and populations. J. Natl. Cancer Inst. 91:916-32.
2. Baker SJ, et al. (1989) Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science. 244:217-21.
3. Bos JL, et al. (1987) Prevalence of ras gene mutations in human colorectal cancers. Nature. 327:293-7.
4. Fearon ER, et al. (1990) Identification of a chromosome 18q gene that is altered in colorectal cancers. Science. 247:49-56.
5. Kinzler KW, et al. (1991) Identification of a gene located at chromosome 5q21 that is mutated in colorectal cancers. Science. 251:1366-70.
6. de la Chapelle A. (2004) Genetic predisposition to colorectal cancer. Nat. Rev. Cancer. 4:769-80.
7. Houlston RS, Tomlinson IP. (2001) Polymorphisms and colorectal tumor risk. Gastroenterology. 121:282-301.
8. Dipple KM, McCabe ER. (2000) Modifier genes convert "simple" Mendelian disorders to complex traits. Mol. Genet. Metab. 71:43-50.
9. Houlston R, Crabtree M, Phillips R, Tomlinson I. (2001) Explaining differences in the severity of familial adenomatous polyposis and the search for modifier genes. Gut. 48:1-5.
10. Lynch HT, et al. (1988) Natural history of colorectal cancer in hereditary nonpolyposis colorectal cancer (Lynch syndromes I and II). Dis. Colon Rectum. 31:439-44.
11. Scott RJ, et al. (2001) Hereditary nonpolyposis colorectal cancer in 95 families: differences and similarities between mutation-positive and mutationnegative kindreds. Am. J. Hum. Genet. 68:118-27.
12. Felix R, et al. (2006) GSTM1 and GSTT1 polymorphisms as modifiers of age at diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC) in a homogeneous cohort of individuals carrying a single predisposing mutation. Mutat. Res. 602:175-81.
13. Heinimann K, et al. (1999) N-acetyltransferase 2 influences cancer prevalence in hMLH1/hMSH2 mutation carriers. Cancer Res. 59:3038-40.
14. Menin C, et al. (2006) Association between MDM2-SNP309 and age at colorectal cancer diagnosis according to p53 mutation status. J. Natl. Cancer Inst. 98:285-8.
15. Talseth BA, et al. (2008) Aurora-A and Cyclin D1 polymorphisms and the age of onset of colorectal cancer in hereditary nonpolyposis colorectal cancer. Int. J. Cancer. 122:1273-7.
16. Talseth BA, et al. (2006) Genetic polymorphisms in xenobiotic clearance genes and their influence on disease expression in hereditary nonpolyposis colorectal cancer patients. Cancer Epidemiol. Biomarkers Prev. 15:2307-10.
17. Zecevic M, et al. (2006) IGF1 gene polymorphism and risk for hereditary nonpolyposis colorectal cancer. J. Natl. Cancer Inst. 98:139-43.
18. Eis PS, et al. (2005) Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc. Natl. Acad. Sci. U. S. A. 102:3627-32.
19. Lu J, et al. (2005) MicroRNA expression profiles classify human cancers. Nature. 435:834-8.
20. Michael MZ, O'Connor SM, van Holst Pellekaan NG, Young GP, James RJ. (2003) Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol. Cancer Res. 1:882-91.
21. Chen K, Rajewsky N. (2006) Natural selection on human microRNA binding sites inferred from SNP data. Nat. Genet. 38:1452-6.
22. Chen J, Liu B, Liu Y, et al. (2002) A novel gene IC53 stimulates ECV304 cell proliferation and is upregulated in failing heart. Biochem. Biophys. Res. Commun. 294:161-6.
23. Stav D, Bar I, Sandbank J. (2007) Usefulness of CDK5RAP3, CCNB2, and RAGE genes for the diagnosis of lung adenocarcinoma. Int. J. Biol. Markers. 22:108-13.
24. Jiang H, Luo S, Li H. (2005) Cdk5 activatorbinding protein C53 regulates apoptosis induced by genotoxic stress via modulating the G2/M DNA damage checkpoint. J. Biol. Chem. 280:20651-9.
25. Wang J, An H, Mayo MW, Baldwin AS, Yarbrough WG. (2007) LZAP, a putative tumor suppressor, selectively inhibits NF-kappaB. Cancer Cell. 12:239-51.
26. Wang J, He X, Luo Y, Yarbrough WG. (2006) A novel ARF-binding protein (LZAP) alters ARF regulation of HDM2. Biochem. J. 393:489-501.
27. Kohler G, Milstein C. (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 256:495-7.
28. Huang HS, et al. (1997) The enhanced tumorigenic activity of a mutant epidermal growth factor receptor common in human cancers is mediated by threshold levels of constitutive tyrosine phosphorylation and unattenuated signaling. J Biol. Chem. 272:2927-35.
29. Brakebusch C, Bouvard D, Stanchi F, Sakai T, Fassler R. (2002) Integrins in invasive growth. J. Clin. Invest. 109:999-1006.
30. Lee JW, Juliano RL. (2000) Alpha5beta1 integrin protects intestinal epithelial cells from apoptosis through a phosphatidylinositol 3-kinase and protein kinase B-dependent pathway. Mol. Biol. Cell. 11:1973-87.
31. Shao J, Sheng H, Inoue H, Morrow JD, DuBois RN. (2000) Regulation of constitutive cyclooxygenase-2 expression in colon carcinoma cells. J Biol. Chem. 275:33951-6.
32. Sheng H, Shao J, Washington MK, DuBois RN. (2001) Prostaglandin E2 increases growth and motility of colorectal carcinoma cells. J. Biol. Chem. 276:18075-81.
33. Ghatak S, Misra S, Toole BP. (2002) Hyaluronan oligosaccharides inhibit anchorage-independent growth of tumor cells by suppressing the phosphoinositide 3-kinase/Akt cell survival pathway. J. Biol. Chem. 277:38013-20.
34. Almeida EA, et al. (2000) Matrix survival signaling: from fibronectin via focal adhesion kinase to c-Jun NH(2)-terminal kinase. J. Cell Biol. 149:741-54.
35. Fukumoto S, et al. (2001) Akt participation in the Wnt signaling pathway through Dishevelled. J. Biol. Chem. 276:17479-83.
36. Holland EC, et al. (2000) Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice. Nat. Genet. 25:55-7.
37. Zimmermann S, Moelling K. (1999) Phosphorylation and regulation of Raf by Akt (protein kinase B). Science. 286:1741-4.
38. Ching YP, Qi Z, Wang JH. (2000) Cloning of three novel neuronal Cdk5 activator binding proteins. Gene. 242:285-94.
39. Kim E, Chen F, Wang CC, Harrison LE. (2006) CDK5 is a novel regulatory protein in PPARgamma ligand-induced antiproliferation. Int. J. Oncol. 28:191-4.